Genetic heterogeneity of primary familial and congenital polycythemia

Primary familial and congenital polycythemia (PFCP) is an inherited disorder of erythroid progenitor cells resulting in elevated erythrocyte mass. Several mutations of the erythropoietin receptor (EPOR) gene have been associated with PFCP, although in a few families the linkage between the EPOR gene and PFCP has been excluded. To examine the role of EPOR mutations in the pathogenesis of PFCP, we studied 43 unrelated PFCP subjects. Erythroid culture data were available in 26 subjects, and in all these subjects, we observed hypersensitivity of erythroid progenitors to erythropoietin (EPO). We screened all EPOR gene exons for mutations using ribonuclease cleavage assay and protein truncation test. We detected five mutations in exon VIII of the EPOR gene, four of which we reported earlier. A new EPOR gene mutation was found (G5959T) that changes codon 425 GAG to a termination codon, resulting in truncation of the EPOR by 84 amino acids. The G5959T mutation was found to segregate with the disease in the affected family and represents another example of a nonsense mutation associated with PFCP. We also report the first intronic mutation (A2706T) of the EPOR gene. The finding of only five disease‐causing mutations in our PFCP patient pool of 43 subjects (12%) indicates that EPOR gene mutations are not the major genetic defect associated with PFCP. The hypersensitivity of erythroid progenitors to EPO seen in all examined PFCP subjects suggests a dominant lesion of an as yet unidentified gene either at the level of the EPOR signaling pathway or another erythropoiesis regulating pathway. Am. J. Hematol. 68:115–121, 2001. © 2001 Wiley‐Liss, Inc.

[1]  J. Kere,et al.  Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state. , 1999, Blood.

[2]  M. Arcasoy,et al.  A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation. , 1999, Experimental hematology.

[3]  R. Kralovics,et al.  Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia. , 1998, The Journal of clinical investigation.

[4]  M. McMullin,et al.  Erythrocytosis due to a mutation in the erythropoietin receptor gene , 1998, British journal of haematology.

[5]  R. Kralovics,et al.  The erythropoietin receptor gene is not linked with the polycythemia phenotype in a family with autosomal dominant primary polycythemia. , 1997, Proceedings of the Association of American Physicians.

[6]  K. Kishi,et al.  Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor , 1997, British journal of haematology.

[7]  R. Kralovics,et al.  Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias. , 1997, Blood.

[8]  M. Arcasoy,et al.  Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene. , 1997, Blood.

[9]  Weinberg Rs.  In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders. , 1997 .

[10]  J. Prchal,et al.  Erythropoietin receptor mutations and human disease. , 1997, Seminars in hematology.

[11]  W. Vainchenker,et al.  Missense mutation of the erythropoietin receptor is a rare event in human erythroid malignancies. , 1996, Blood.

[12]  G. Semenza,et al.  Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. , 1995, Blood.

[13]  Ursula Klingmüller,et al.  Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals , 1995, Cell.

[14]  D. Banville,et al.  A sensitive method for detection of mutations--a PCR-based RNase protection assay. , 1995, DNA and cell biology.

[15]  P. Mayeux,et al.  A translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated protein. , 1995, Blood.

[16]  A. D’Andrea,et al.  Mutation in the negative regulatory element of the erythropoietin receptor gene in a case of sporadic primary polycythemia. , 1994, Experimental hematology.

[17]  J. D. den Dunnen,et al.  Protein truncation test (PTT) for rapid detection of translation-terminating mutations. , 1993, Human molecular genetics.

[18]  L. Sokol,et al.  Primary familial and congenital polycythaemia , 1993, The Lancet.

[19]  A. de la Chapelle,et al.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Eaves,et al.  Familial and congenital polycythemia in three unrelated families. , 1992, Blood.

[21]  E. Ikkala,et al.  Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. , 1991, Blood.

[22]  L. Zon,et al.  The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains , 1991, Molecular and cellular biology.

[23]  H. Lodish,et al.  Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity , 1990, Nature.

[24]  J. Prchal,et al.  Autosomal dominant polycythemia. , 1985, Blood.